Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -60.19M | -390.44% | $ 15.42M |
3/31/2025 | $ -58.95M | -920.6% | $ 6.4M |
12/31/2024 | $ -64.85M | -1050.88% | $ 6.17M |
9/30/2024 | $ -71.83M | -1065.37% | $ 6.74M |
6/30/2024 | $ -72.88M | -724.33% | $ 10.06M |
3/31/2024 | $ -77.93M | -600.11% | $ 12.99M |
12/31/2023 | $ -85.94M | -473.71% | $ 18.14M |
9/30/2023 | $ -85.63M | -385.03% | $ 22.24M |
6/30/2023 | $ -82.54M | -350.72% | $ 23.54M |
3/31/2023 | $ -83.28M | -251.4% | $ 33.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ARBUTUS BIOPHARMA CORP is calculated as follows: CF - Operations [ $ -49.78M ] / Revenues [ $ 6.15M ]
(=) OCF % [ -809.94% ]
Minimum
Sep 30, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |